Company intelligence / Profile preview

Dexon Biotech

Panchkula, Haryana, India

Ownership: Private
Development stage: Other

Overview

Dexon Biotech is an Indian pharmaceutical company focused on the manufacturing and marketing of a wide range of generic pharmaceutical formulations. The company's product portfolio includes antibiotics, analgesics, anti-inflammatory drugs, and treatments for gastrointestinal and respiratory conditions. Dexon Biotech operates primarily as a commercial-stage entity, providing affordable healthcare solutions through various dosage forms such as tablets, capsules, and injectables. They emphasize quality control and compliance with regional regulatory standards to serve the domestic Indian market.

Therapeutic areas: Infectious DiseasesGastroenterologyNeurologyImmunology
Modalities: Small molecule
Industry: Pharma

Drug pipeline

1 asset

Dexozyme

Unknown

Beyond the preview

Go deeper on Dexon Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dexon Biotech.

Explore the full profile